Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.045x

Based on the latest financial reports, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a cash flow conversion efficiency ratio of 0.045x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥1.84 Billion ≈ $269.92 Million USD) by net assets (CN¥41.12 Billion ≈ $6.02 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Review Guangzhou Baiyunshan Pharmaceutical Hold leverage flexibility ratio to assess the company's free cash flow relative to its total liabilities.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd - Cash Flow Conversion Efficiency Trend (2000–2025)

This chart illustrates how Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see Guangzhou Baiyunshan Pharmaceutical Hold (600332) market capitalisation for the company's overall valuation and market capitalisation.

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Millrose Properties, Inc. NYSE:MRP	0.136x
Waystar Holding Corp. Common Stock NASDAQ:WAY	0.022x
Shanghai Friendess Electronics Tech SHG:688188	0.037x
Jiangsu Hoperun Software Co Ltd SHE:300339	0.130x
Sinopec Oilfield Service Corp SHG:600871	0.368x
Global Power Synergy PCL BK:GPSC	0.044x
X-Energy, Inc. Class A Common Stock NASDAQ:XE	-0.064x
Shenzhen Energy Group Co Ltd SHE:000027	0.085x

Annual Cash Flow Conversion Efficiency for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)

The table below shows the annual cash flow conversion efficiency of Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd from 2000 to 2025. View Guangzhou Baiyunshan Pharmaceutical Hold stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥41.12 Billion ≈ $6.02 Billion	CN¥260.23 Million ≈ $38.08 Million	0.006x	-93.06%
2024-12-31	CN¥37.77 Billion ≈ $5.53 Billion	CN¥3.44 Billion ≈ $503.74 Million	0.091x	-18.54%
2023-12-31	CN¥36.68 Billion ≈ $5.37 Billion	CN¥4.10 Billion ≈ $600.49 Million	0.112x	-46.23%
2022-12-31	CN¥33.64 Billion ≈ $4.92 Billion	CN¥7.00 Billion ≈ $1.02 Billion	0.208x	+14.89%
2021-12-31	CN¥31.33 Billion ≈ $4.58 Billion	CN¥5.67 Billion ≈ $830.21 Million	0.181x	+772.92%
2020-12-31	CN¥28.21 Billion ≈ $4.13 Billion	CN¥585.19 Million ≈ $85.63 Million	0.021x	-89.26%
2019-12-31	CN¥25.99 Billion ≈ $3.80 Billion	CN¥5.02 Billion ≈ $734.93 Million	0.193x	-14.27%
2018-12-31	CN¥23.14 Billion ≈ $3.39 Billion	CN¥5.22 Billion ≈ $763.39 Million	0.225x	+136.80%
2017-12-31	CN¥19.26 Billion ≈ $2.82 Billion	CN¥1.83 Billion ≈ $268.33 Million	0.095x	-31.26%
2016-12-31	CN¥17.65 Billion ≈ $2.58 Billion	CN¥2.44 Billion ≈ $357.73 Million	0.138x	-38.08%
2015-12-31	CN¥8.68 Billion ≈ $1.27 Billion	CN¥1.94 Billion ≈ $284.17 Million	0.224x	+1.05%
2014-12-31	CN¥7.96 Billion ≈ $1.16 Billion	CN¥1.76 Billion ≈ $257.75 Million	0.221x	+16.05%
2013-12-31	CN¥7.02 Billion ≈ $1.03 Billion	CN¥1.34 Billion ≈ $195.96 Million	0.191x	+59.04%
2012-12-31	CN¥4.22 Billion ≈ $618.15 Million	CN¥506.53 Million ≈ $74.12 Million	0.120x	+359.40%
2011-12-31	CN¥3.90 Billion ≈ $569.99 Million	CN¥-180.05 Million ≈ $-26.35 Million	-0.046x	-330.06%
2010-12-31	CN¥3.64 Billion ≈ $532.87 Million	CN¥73.17 Million ≈ $10.71 Million	0.020x	-84.45%
2009-12-31	CN¥3.40 Billion ≈ $497.76 Million	CN¥439.39 Million ≈ $64.30 Million	0.129x	+6725.17%
2008-12-31	CN¥3.22 Billion ≈ $471.91 Million	CN¥6.10 Million ≈ $893.13K	0.002x	-98.34%
2007-12-31	CN¥3.29 Billion ≈ $482.05 Million	CN¥375.74 Million ≈ $54.98 Million	0.114x	+766.65%
2006-12-31	CN¥2.95 Billion ≈ $432.29 Million	CN¥38.88 Million ≈ $5.69 Million	0.013x	-74.75%
2005-12-31	CN¥2.81 Billion ≈ $410.74 Million	CN¥146.32 Million ≈ $21.41 Million	0.052x	-31.47%
2004-12-31	CN¥2.64 Billion ≈ $385.80 Million	CN¥200.54 Million ≈ $29.35 Million	0.076x	+2991.17%
2003-12-31	CN¥2.60 Billion ≈ $379.91 Million	CN¥-6.83 Million ≈ $-999.50K	-0.003x	-103.77%
2002-12-31	CN¥2.42 Billion ≈ $354.54 Million	CN¥169.01 Million ≈ $24.73 Million	0.070x	+13.67%
2001-12-31	CN¥2.28 Billion ≈ $334.18 Million	CN¥140.15 Million ≈ $20.51 Million	0.061x	-67.96%
2000-12-31	CN¥1.50 Billion ≈ $219.25 Million	CN¥286.95 Million ≈ $41.99 Million	0.192x	--

About Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

SHG:600332 China Medical Distribution

Market Cap

$4.44 Billion

CN¥30.35 Billion CNY

Market Cap Rank

#3869 Global

#565 in China

Share Price

CN¥21.59

Change (1 day)

+0.42%

52-Week Range

CN¥19.77 - CN¥27.59

All Time High

CN¥41.57